Final Report - SARS/FLU VACCINE (Development of a combined Influenza/SARS vaccine)
Project ID: 512054Funded under: FP6-LIFESCIHEALTH
This is the final report for the SARS/FLU project which focused on the development of a chimeric vaccine based on the Avir Green Hills Biotechnology's replication deficient influenza virus which was developed for use as a safe vector for foreign antigens. By using a delNS1 vector system, a significant immune response is expected, as these vectors induce a strong interferon response. The report highlights the progress made by the project and notes that the output of this cooperative Research and development (R&D) project will be further pursued by the involved partners. Based on positive preclinical results the initiation of the clinical trials of this vaccine approach is planned.
Download application/zip (22377)
Record Number: 12888 / Last updated on: 2011-04-14